What Synetic Life Sciences does

Synetic Life Sciences is positioned in the source material as a specialist management consulting firm dedicated to the life sciences sector, headquartered in London, United Kingdom. Its stated operating model is to serve pharmaceutical, biotechnology, and medtech clients through a portfolio of five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (a data and analytics offering), and AI-Powered Solutions (covering AI strategy, governance, use case definition, and adoption). The firm's go-to-market is sales-led and enterprise-focused, engaging directly with pharmaceutical executives and leadership teams on multi-year, project-based engagements with custom pricing.

The firm's underlying technology layer is described as comprising consulting services "enabled by AI and advanced analytics capabilities," with Lucid Connected Intelligence positioned as the connective platform that integrates analytics across the service portfolio and AI-Powered Solutions handling AI strategy, governance, use case definition, and build/adoption work. Proprietary content assets include an extensive library of case studies (covering pipeline prioritization, global evidence generation, medical affairs operating model design, portfolio buy-and-build, and patient support program launches) and published white papers on Decentralised Clinical Trials, Medical Operations of the Future, and Medical Affairs KPIs.

The firm competes against generalist management consultancies by emphasizing exclusive life sciences focus, senior experienced consultants, and what it characterizes as being "big enough but not too big." Its revenue model is professional services fees on custom engagement-based pricing, with multi-year contract cadences implied. The source material contains no disclosed revenue, no named customer logos, no headcount figures, and no funding history. The firmographic record lists founding year 2020, while the operating company's own materials claim "over 20 years" of brand reputation — a discrepancy the source does not resolve. No partnerships, acquisitions, regulatory actions, or leadership team disclosures beyond a single US Vice President are present in the input data.

Name

Synetic Life Sciences

Legal name

Lucid Group

Website

https://syneticlifesciences.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Synetic Life Sciences is a London-based specialist consulting firm dedicated to life sciences, offering strategy consulting, medical and commercial communications, connected intelligence, and AI-powered solutions to pharmaceutical, biotech, and medtech clients.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Innovation, Product & R&D Consulting (BPAHACAM), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Life sciences consulting
• Pharmaceutical strategy consulting
• Biopharma advisory services
• Medical affairs consulting
• Healthcare management consulting

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Strategy Consulting Services: Management consulting engagements providing expertise-led and outcome-driven support for pharmaceutical companies across asset strategy, business transformation, and customer value initiatives. Projects include market evaluation, launch excellence planning, operating model design, and digital transformation programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Synetic Life Sciences is a specialist consulting firm focused on the life sciences, providing strategic management consulting and advisory services to biopharma companies, providers and investors. The firm delivers five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions for pharma transformation.

Product overview

Lucid Group is a strategic management consulting firm dedicated to life sciences, offering a platform of consulting services that help pharma leaders unlock asset potential, transform functions across development and commercial operations, and create value for customers and patients. The portfolio consists of five integrated capabilities: Strategy Consulting (core offering covering asset strategy, business design and transformation, and patient/customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions (AI strategy and adoption). These capabilities work together to drive transformation enabled by AI and advanced analytics.

Differentiator

Problem solved

Functional benefit

Brands

• Lucid Strategy Consulting: The strategic management consulting arm of Lucid Group, offering expertise in asset strategy, business design & transformation, and patient & customer value for life sciences companies.
• Lucid Connected Intelligence
• AI-Powered Solutions

Products and services

• Strategy Consulting Strategic management consulting dedicated to life sciences, helping pharma clients with asset strategy, business design and transformation, and patient and customer value delivery across market, asset and portfolio evaluation, launch excellence, and lifecycle planning.
• Scientific and Medical Communications Medical communications services supporting pharma companies in engaging with healthcare professionals and stakeholders, delivered under the firm's capabilities portfolio.
• Commercial Communications Commercial communications services helping pharma companies adapt go-to-market strategies and operating models through consulting engagement.
• Lucid Connected Intelligence Data and analytics capability enabling pharma companies to leverage connected intelligence across their operations, integrated with the firm's consulting capabilities.
• AI-Powered Solutions AI-enabled consulting solutions incorporating AI strategy, governance, use case definition, build and adoption to support pharma transformation across Medical Affairs and commercial operations.

Quantifiable outcome

• Accelerated time-to-approval for pharma assets
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Syneos Health Consulting: Syneos Health combines commercial consulting with contract sales and clinical solutions for pharma/biotech, competing on commercial transformation and launch excellence engagements at larger scale than specialist consultancies.
• IQVIA: IQVIA is the largest life sciences technology and analytics provider, combining data, RWD, and consulting services for pharma. It competes with the firm on strategy and Medical Affairs transformation engagements, though at vastly greater scale and with proprietary data assets.
• Boston Consulting Group (Healthcare): BCG's Healthcare practice serves global pharma and biotech on strategy, launch, and operating model transformation, frequently partnering with biopharma leadership teams on multi-year engagements similar in scope to the firm's Business Design & Transformation work.
• McKinsey & Company (Pharma Practice): McKinsey's Pharmaceuticals & Medical Products practice covers the full lifecycle from R&D strategy through commercial transformation, often with global transformation programs. It is the dominant generalist incumbent competing for the same enterprise-level pharma mandates.

Direct peers

• L.E.K. Consulting: L.E.K. is a global strategy consulting firm with a sizable dedicated life sciences practice covering pharma, biotech, and medtech strategy. It competes directly on asset strategy, launch excellence, and commercial transformation mandates.
• Trinity Life Sciences: Trinity Life Sciences is a life sciences-focused commercial strategy and insights firm serving pharma and biotech with evidence generation, brand strategy, and launch planning — closely aligned to the firm's Patient & Customer Value and Asset Strategy capabilities.
• ZS Associates: ZS Associates is a global consulting firm exclusively dedicated to life sciences and healthcare, with deep expertise in pharma strategy, sales/marketing, and AI/analytics — a directly comparable specialist competitor with a similar domain-only positioning and analytics-embedded services.
• ClearView Healthcare Partners: ClearView is a boutique life sciences strategy firm focused on biopharma asset strategy, commercial planning, and market access. It is a close peer on specialty pharma and biotech mandates.
• Charles River Associates: CRA's Life Sciences practice provides strategy and economic consulting to pharma and biotech, including portfolio strategy, pricing, and evidence generation — directly comparable to the firm's Asset Strategy and Business Transformation offerings.
• Putnam Associates: Putnam is a specialized strategy consulting firm serving biopharma and MedTech, with deep expertise in asset and portfolio strategy, launch planning, and commercial model design — directly comparable to the firm's core asset strategy offerings.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/synetic-life-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synetic Life Sciences